Brian Thomas, Metagenomi CEO

Gene edit­ing com­pa­ny Metageno­mi sub­mits IPO pa­per­work in third planned biotech list­ing of 2024

Metageno­mi sub­mit­ted its plans for an ini­tial pub­lic of­fer­ing on Fri­day night, in what would be one of the on­ly pre­clin­i­cal gene edit­ing biotechs to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.